EPAPLUS ARTHICARE COLLAGEN LEMON SS POWDER ANTIOX 30D
Food supplement declared in France, decision dated 27 February 2025
EPAPLUS ARTHICARE COLLAGEN LEMON SS POWDER ANTIOX 30D (EPAPLUS) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- EPAPLUS
- Food business operator placing the product on the market
- Peroxfarma, S.A.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Powder
- Daily dose
- 10,77
- Directions for use
- Prendre une mesure de Epaplus Arthicare dissous dans de l'eau, du jus ou un autre liquide (250 ml). Ne pas chauffer.
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Children (under 12), Kidney disease
- Objectives stated by the manufacturer (these are not authorised claims)
- Joints
- Flavourings
- LEMON
Declaration 87701, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Substances
| Name | Per day |
|---|---|
| collagène hydrolysé | 10,000 mg |
| acide citrique | 100 mg |
| acide hyaluronique | 25 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Carbonate de magnésium | Magnésium | 250 mg | 300 mg |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Riboflavine | Vitamine B2 (riboflavine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| L-ascorbate de calcium | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
| Acétate de DL-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
Additives
E955
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Les compléments alimentaires ne doivent pas être utilisés comme substitut d'un régime alimentaire équilibré. Ne pas dépasser la dose journalière expressément recommandée. Tenir hors de portée des jeunes enfants. Conserver hermétiquement fermé dans un endroit frais et sec.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- collagène hydrolysé
Read the warning, when it applies and the studies cited
Hydrolyzed Collagen
Route of administration: Oral
Cautions and warnings
Condition of application: Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Applies to products providing more than 2.8 g hydrolyzed collagen, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).
Sources cited by Health Canada (2)
- Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.
- Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease, 10th edition. Philadelphia (PA): Lippincott Williams and Wilkins, 2006.
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).
Sources cited by Health Canada (1)
- Moskowitz RW. Role of collagen hydrolysate in bone and joint disease. Seminars in Arthritis and Rheumatism 2000;30(2):87-99. PubMed Randomised trial
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : EPAPLUS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.